Rocket Pharmaceuticals, Inc.RCKTNASDAQ
LOADING
|||
EBITDA Over Time
Below historical average, strong compound growth.
Left:
||||
Earnings before interest, taxes, depreciation, and amortization
Latest
$-247.49M
↓ 103% below average
Average (9y)
$-121.77M
Historical baseline
Range
High:$-20.26M
Low:$-247.49M
CAGR
+32.1%
Consistent expansion
| Period | Value | Change |
|---|---|---|
| 2024 | $-247.49M | -4.6% |
| 2023 | $-236.62M | -10.7% |
| 2022 | $-213.69M | -35.4% |
| 2021 | $-157.81M | -19.9% |
| 2020 | $-131.59M | -85.0% |
| 2019 | $-71.14M | +0.0% |
| 2018 | $-71.16M | -166.1% |
| 2017 | $-26.74M | +35.2% |
| 2016 | $-41.27M | -103.7% |
| 2015 | $-20.26M | - |